117 related articles for article (PubMed ID: 18275399)
21. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
Toft EL; Kaae SE; Malmqvist J; Brodersen J
Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
[No Abstract] [Full Text] [Related]
22. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
23. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
24. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
Platt KD; Kurlander JE; Zikmund-Fisher BJ; Lipson R; Knaus M; Waljee AK; Saini SD
Am J Gastroenterol; 2019 Oct; 114(10):1685-1687. PubMed ID: 31464741
[TBL] [Abstract][Full Text] [Related]
25. Planning for a possible national colorectal cancer screening programme.
Garvican L
J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
Damery S; Clifford S; Wilson S
BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
[TBL] [Abstract][Full Text] [Related]
27. The National Health Service Bowel Cancer Screening Program: the early years.
Rees CJ; Bevan R
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):421-37. PubMed ID: 23899282
[TBL] [Abstract][Full Text] [Related]
28. Factors Associated with Informed Decisions and Participation in Bowel Cancer Screening among Adults with Lower Education and Literacy.
Smith SK; Simpson JM; Trevena LJ; McCaffery KJ
Med Decis Making; 2014 Aug; 34(6):756-72. PubMed ID: 24421292
[TBL] [Abstract][Full Text] [Related]
29. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study.
Chapple A; Ziebland S; Hewitson P; McPherson A
Soc Sci Med; 2008 Jun; 66(12):2425-35. PubMed ID: 18358581
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
[TBL] [Abstract][Full Text] [Related]
31. Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography.
de Haan MC; de Wijkerslooth TR; Stoop E; Bossuyt P; Fockens P; Thomeer M; Kuipers EJ; Essink-Bot ML; van Leerdam ME; Dekker E; Stoker J
Patient Educ Couns; 2013 Jun; 91(3):318-25. PubMed ID: 23399437
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer screening: Associations between information provision, attitudes and intended participation.
Brandhof SD; Fagerlin A; Hawley S; Toes-Zoutendijk E; Trevena L; McCaffery K; Korfage IJ
Patient Educ Couns; 2018 Mar; 101(3):546-550. PubMed ID: 28899711
[TBL] [Abstract][Full Text] [Related]
33. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
[TBL] [Abstract][Full Text] [Related]
34. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
35. A qualitative investigation of factors influencing participation in bowel screening in New South Wales.
Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Travaglia J
Health Promot J Austr; 2016 Apr; 27(1):48-53. PubMed ID: 26859797
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.
McDonald R; Tomlins A; Smith S; Harmston C
J Clin Pathol; 2013 Apr; 66(4):330-4. PubMed ID: 23288919
[TBL] [Abstract][Full Text] [Related]
37. The importance of people's values and preferences for colorectal cancer screening participation.
Fritzell K; Stake Nilsson K; Jervaeus A; Hultcrantz R; Wengström Y
Eur J Public Health; 2017 Dec; 27(6):1079-1084. PubMed ID: 28160484
[TBL] [Abstract][Full Text] [Related]
38. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.
Benito L; Farre A; Binefa G; Vidal C; Cardona A; Pla M; García M
Cancer Causes Control; 2018 Jan; 29(1):103-114. PubMed ID: 29170881
[TBL] [Abstract][Full Text] [Related]
39. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
40. Chinese peoples' perceptions of colorectal cancer screening: a New Zealand perspective.
Bong G; McCool J
N Z Med J; 2011 Mar; 124(1331):29-38. PubMed ID: 21725410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
